Maisonneuve-Rosemont Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01942460
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Dr. Jean-Sebastien Delisle, MD, PhD